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Abstract
Background: Jena Virus (JV), a bovine Norovirus, causes enteric disease in cattle and represents a potential model for the
study of enteric norovirus infection and pathogenesis. The positive sense RNA genome of JV is organised into ORF1 (non-
structural proteins), ORF2 (major capsid protein) and ORF3 (minor capsid protein). The lack of a cell culture system for
studying JV replication has meant that work to date has relied upon in vitro systems to study non-structural protein
synthesis and processing.
Principal Findings: Only two of the three major ORF1 proteins were identified (p110 and 2C) following in vitro translation of
JV RNA, the N-term protein was not detected. The N-term encoding genomic sequence (59GS) was tested for IRES-like
function in a bi-cistronic system and displayed no evidence of IRES-like activity. The site of translation initiation in JV was
determined to be at the predicted nucleotide 22. Following the insertion of an epitope within the 59GS the JV N-term
protein was identified in vitro and within RNA transfected cells.
Conclusions: The in vitro transcription/translation system is currently the best system for analysing protein synthesis and
processing in JV. Unlike similarly studied human noroviruses JV initially did not appear to express the N-terminal protein,
presenting the possibility that the encoding RNA sequence had a regulatory function, most likely involved in translation
initiation in an IRES-like manner. This was not the case and, following determination of the site of translation initiation the
N-term protein was detected using an epitope tag, both in vitro and in vivo. Although slightly larger than predicted the N-
term protein was detected in a processed form in vivo, thus not only demonstrating initial translation of the ORF1
polyprotein but also activity of the viral protease. These findings indicate that the block to noroviral replication in cultured
cells lies elsewhere.
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Introduction
Jena virus, a bovine norovirus, is a member of the Caliciviridae
family of positive sense RNA viruses and was first isolated from the
diarrhoeic stools of newborn calves [1,2]. JV is a type I genogroup
III (GIII) norovirus which is closely related to the type II GIII
bovine noroviruses Newbury agent 2 and Dumfries [3,4]. The
GIII noroviruses are responsible for causing enteric disease in
cattle [2,5] and, thus, likely share a similar tissue tropism to the
human-associated enteric noroviruses. Like human noroviruses [6]
bovine noroviruses have a high seroprevalence [4]. JV is therefore
a potentially useful model for studying the molecular biology of
enteric norovirus pathogenesis and replication.
The 7.3 kb polyadenylated RNA genome of JV has been
characterised previously [7] and, like other noroviruses, is
organised into 3 open reading frames (ORFs). ORF1 encodes
the non-structural proteins in the form of a large 185 kDa
polyprotein, which is subsequently cleaved into functional
replication proteins by the viral encoded 3C-like protease.
ORF2 encodes the structural capsid protein (56 kDa) and ORF3
encodes a small basic protein, which has been shown to function as
a minor capsid component [8]. JV ORF1 is consistent with other
caliciviruses in that it encodes a 39 kDa 2C-like nucleoside
triphosphatase (NTPase), a 3C-like protease and a 56 kDa 3D-like
RNA-dependent RNA polymerase [7,9–13]. However, the
genomic sequence within the 59 region of JV ORF1 (59GS)
displays a high level of divergence. This divergence is mainly
attributed to the presence of several proline-encoding polypyr-
imidine tracts within the region predicted to encode a 35 kDa N-
terminal protein [7]. The predicted size of N-terminal proteins
relative to the size of the respective 2C proteins differs within the
norovirus genus. Within the GI noroviruses, such as Southampton
virus, the N-terminal protein (44.8 kDa) is larger in size compared
to the 2C protein (39.6 kDa). This is in contrast to the GII
noroviruses, such as Lordsdale virus and Camberwell virus, in that
the N-terminal protein is smaller in size compared to the 2C
protein [11,14]. This is also the case for Jena virus in which the
predicted JV N-terminal protein (35 kDa) is smaller than the JV
2C protein (39 kDa) [7].
The norovirus N-terminal protein varies in relative size across
the genus, and the encoding sequence bears no similarity to other
cellular or viral proteins. Alignment of the N-term protein
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sequences of various noroviruses indicates little similarity between
genogroups within the first 180 residues, however towards the C-
terminal end of the protein similarity between the amino acid
residues increases. Recent studies investigating the functions of the
Norwalk virus N-terminal protein have successfully demonstrated
association with the Golgi apparatus in transfected cells [15]. In
addition this study also identified a picornaviral 2B like region
within the N-terminal protein, suggesting that the protein is
involved with host cell membrane interactions, reinforcing other
findings that have suggested that the Norwalk virus N-terminal
protein disrupts intracellular protein trafficking, including proteins
destined for the host cell membrane [16]. A 3C protease-mediated
cleavage event within the N-terminal protein (37 kDa) was
described for Camberwell virus, a genogroup 2 norovirus, yielding
proteins of 22 kDa and 15 kDa [17]. Based on these observations
and location within the genome it was hypothesised that the N-
terminal protein of noroviruses corresponds to the 2AB region in
picornaviruses.
Another possibility is that the N-term encoding RNA itself
serves to function as a translational enhancer by interacting with
cellular proteins involved in translation. Indeed, this phenomenon
has been previously reported for Norwalk virus, within which a
double stem loop structure has been predicted at the 59 end of the
genomic RNA [18]. It was subsequently demonstrated that
elements within the 59 end of Norwalk virus bind specifically with
cellular proteins such as La, PTB and PCBP2 [19] which have all
been implicated in IRES-mediated cap-independent translation in
the closely related picornaviruses [20–23]. In this study the role of
the JV 59GS was investigated, including its potential to direct cap-
independent translation initiation. The precise location of
translation initiation in JV was also investigated.
Results and Discussion
JV ORF1 Polyprotein Processing
Previous studies of norovirus polyprotein processing have
yielded three major products following in vitro transcription and
translation, representing the uncleaved 3ABCD, N-term and 2C
proteins. However, initial analysis of JV polyprotein processing
indicated that only two major proteins are synthesised initially
which, based on molecular weight predictions, are the 3ABCD
(110 kDa) and the 2C (39 kDa). The lack of an N-terminal protein
encoded by the JV 59GS, predicted to be 35.3 kDa, is unique
among the noroviruses that have been studied in this way. The in
vitro transcription and translation profile for JV was therefore
studied in more detail. As initial experiments had analysed TNTH
reactions following a 1 hr incubation, reaction aliquots were
harvested at time points before and after the recommended 1 hr
incubation.
The results in Figure 1 show that there are no major reaction
products synthesised prior to the 1 hr time point, at which time the
3ABCD/p110 and 2C/p39 proteins are clearly visible. Extended
incubation past the 1 hr point resulted in further proteolytic
cleavage of p110 that coincided with the appearance of proteins of
the following sizes: 86 kDa, 55 kDa, and 51 kDa. In addition
proteins of 29 kDa, 22 kDa and 20 kDa were also visible at the
24 hr time point (Figure 1, lane 7). The only protein that was
consistently visible following the 1 hr time point was the 2C/p39
protein. Despite prolonged incubation there was no indication that
the N-terminal/p35 protein was synthesised.
A comprehensive study of polyprotein processing within the
murine norovirus (MNV) suggests likely identities for the
equivalent proteins in the similar profile for JV [12]. Using
region specific antisera the authors were able to identify p110 as
the 3ABCD uncleaved precursor, p90 as the 3BCD, p57.5 as the
3D-like polymerase, p52 as a 3ABC precursor and p40 as the 2C-
like NTPase, which was determined by mutagenesis and
microsequencing experiments. The 19 kDa protein was identified
as the 3C-like protease. The antisera used to detect the MNV N-
term protein recognised 3 products; one was the predicted
molecular weight at 39 kDa and the other two bands migrated as
a 45 kDa doublet.
Assessment of translational enhancing potential of the JV
59GS
The 59GS region of JV is highly divergent compared to other
noroviruses, mainly due to the relatively high cytosine content
(32%), which contributes to an overall G/C content of 58%.
There are many polypyrimidine tracts within the sequence,
potentially yielding a relatively high degree of RNA secondary
structure. Previous studies have described potential secondary
RNA structure and interaction with proteins involved with IRES-
mediated translation within the 59 genomic region of Norwalk
virus [18,24]. It was of interest therefore, based on these findings,
to ascertain whether or not the 59GS of JV possessed IRES-like
properties within the context of a ‘Bi-cistronic’ expression system,
independently of other viral proteins, including the VPg which, in
other caliciviruses, has been shown to be associated with
translation initiation factors [25,26].
Traditionally the bi-cistronic vector system has been used to
define potential IRES-like sequences from a variety of viral and
cellular mRNAs, and is recognized as being the standard test for
this function [27]. A bi-cistronic vector is comprised of a 59 and 39
cistron; translation of the 59 cistron being cap-dependent and
translation of the 39 cistron regulated by the putative IRES-like
sequence. Thus, if the 39 cistron is translated in addition to the 59
cistron then the sequence of interest is said to have IRES-like
properties, as translation is initiating internally.
To test for IRES-like function in JV, bi-cistronic constructs were
made with a cap dependent 59 EGFP cistron and a 39 lacZ cistron
under the translational control of either the JV 59GS (pEGFP-C1/
JV59GS/lacZ) or an authentic EMCV IRES (pEGFP-C1/IRES/
lacZ). CRFK cells were transfected with the bi-cistronic constructs
Figure 1. TNTH time course for JV displaying the progressive
stages of post translational polyprotein processing. Molecular
weight marker is represented by lane 1. Lanes 2–7 represent the
following time points; 15 min, 30 min, 1 hr, 2 hr, 4 hr and 24 hr
respectively.
doi:10.1371/journal.pone.0002169.g001
Analysis of the 59 GS of JV
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and, following incubation, were assayed for EGFP and lacZ
expression.
Both constructs were able to direct translation of the EGFP
cistron effectively as expected (Figure 2a and Figure2d). The use of
an authentic EMCV IRES to direct translation of the lacZ cistron
was also effective (Figure 2e), with levels of b-galactosidase activity
comparable to those of the b-galactosidase reporter (Figure 2f).
However, no b-galactosidase activity was detected from cells
transfected with the pEGFP-C1/JV59GS/lacZ construct
(Figure 2b), demonstrating that the JV 59GS was unable to initiate
translation, and therefore, in this context, did not possess any
IRES-like functions.
Translation initiation in JV ORF1
As it was clear that the JV 59GS did not posses any IRES-like
functions it was necessary to determine the location of translation
initiation within ORF1. This was predicted be the ATG encoding
methionine at nucleotide position 22, as it is situated in a
favourable context for translation initiation [7]. To investigate this
multiple translation termination codons (polySTOP) were inserted
into the JV genome within the 3B-encoding region, downstream of
the 59GS, to halt translation at a defined point. In vitro
transcription and translation of this construct would, in theory,
yield a product whose size would relate to the initiation codon used
within the 59GS (Figure 3). To address the unlikely event of
translation read-through or re-initiation downstream of the
polySTOP, which would result in subsequent translation of the
3C protease and cleavage of the truncated ORF1 polyprotein, a
mutation was made within the active site encoding region of the
3C protease within JV ORF1, to prevent any viral mediated
cleavage of ORF1 translation products (JV 3Cmut/polySTOP). A
point mutation of the critical cysteine residue within the highly
conserved GDCG motif to a glycine residue was performed, and
this approach has been described for the successful inactivation of
other norovirus’ 3C activity [28]. In vitro transcription and
translation analysis was performed on JV wild type (Figure 4,
lane 2), JV 3Cmut (Figure 4, lane 3) and JV 3Cmut/polySTOP
(Figure 4, lane 4). The mutation of the critical cysteine residue
Figure 2. Fluorescence microscopy images and light microscopy images following x-gal staining of CRFK cells transfected with: A
and B–pEGFP-C1/JV 59 GS/lacZ, C–no DNA, D and E–pEGFP-C1/IRES/lacZ, F–pSV b-Gal reporter.
doi:10.1371/journal.pone.0002169.g002
Analysis of the 59 GS of JV
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within the 3C region of JV successfully inactivated the 3C
protease, thus a large, .200kDa uncleaved polyprotein is yielded
following TNTH. The major product generated by JV 3Cmut/
polySTOP was calculated to be 103kDa in size. Based on
computer predictions this is in agreement with the initiation of
translation occurring at nucleotide 22, which demonstrates that
the JV N-term protein is translated in full in vitro. At this time it is
not possible to determine whether translation of intracellular VPg-
bound viral RNA initiates at nucleotide 22, although it is likely
given the favourable context in which the initiation codon is
situated.
Immune detection of JV N-term
As the JV N-term was found to be translated in vitro attempts
were made to express and purify the protein in bacteria for
immunisation so that the protein could be identified by radio-
immune precipitation assay (RIPA), as it was possible that the N-
term protein was migrating on gels aberrantly and possibly co-
migrating with 2C. Attempts to express the protein in bacteria
were unsuccessful due to toxicity. Therefore, the 14aa V5 epitope
encoding sequence was cloned in frame into the JV cDNA
construct at nucleotide position 123 (JV V5). The V5 epitope
originates from the P and V proteins of the SV5 paramyxovirus
Figure 3. A-JV ORF1 polyprotein showing mutation to the 3C protease at amino acid 1132 and insertion of the polySTOP cassette
at amino acid 930, as found in the JV 3Cmut/polySTOP construct. B-The possible in vitro transcription and translation products from the 6 in-
frame Met residues within the 59GS and their respective predicted molecular weights. M1 represents the initiation codon found at nucleotide 22
within the JV genome.
doi:10.1371/journal.pone.0002169.g003
Figure 4. Analysis of TNTH products for JV (lane 2), JV 3Cmut
(lane 3) and JV 3Cmut/polySTOP (lane 4), on a 7% SDS PAGE
gel. Molecular weight marker representation is displayed in lane 1. The
major band of approximately 103 kDa in lane 4 is indicative of
translation initiation at nucleotide 22.
doi:10.1371/journal.pone.0002169.g004
Analysis of the 59 GS of JV
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[29], for which a commercially available monoclonal antibody is
used for detection.
Following in vitro transcription and translation of JV V5 a new
product, approximately 42 kDa in size, was visible (Figure 5, lane
2). This product was not observed in any prior analyses of JV. To
confirm that this protein was V5/N-term associated the TNTH
reaction was subjected to RIPA using the anti-V5 antibody
(Figure 5, lane 3). This confirmed expression of the N-term protein
in vitro.
To confirm expression of the V5/N-term protein in cell culture
capped RNA was synthesised from the JV V5 T7 cDNA construct,
which was used to transfect CRFK cells. As there is currently no
host cell line in which to propagate JV the CRFK cell line was
used as it has been shown to support the replication of feline
calicivirus [30]. Confocal immunofluorescence of transfected cells
using the anti-V5 antibody demonstrated expression of the V5/N-
term protein in cultured cells (Figure 6). Expression of the V5/N-
term protein was diffuse and did not co-localise with the Golgi/
ER/plasma membrane marker wheat germ agglutinin (WGA) and
therefore displays a different pattern of cellular expression
compared to Norwalk virus [15]. Cells transfected with the wild
type full length JV RNA were negative for fluorescence (data not
shown).
Lysates of cells transfected with wild type JV and JV/V5 RNA
were subjected to western blot using the anti-V5 antibody
(Figure 7). No product was present for cells transfected with wild
type JV RNA, but a protein of approximately 42 kDa in size was
visible in cells that had been transfected with JV/V5 RNA,
confirming N-term expression and size as seen in the in vitro
system. In addition, this important observation also confirms for
the first time that the JV 3C protease was active in cells transfected
with capped RNA as the size of the V5/N-term indicated
successful cleavage of the protein from the ORF1 polyprotein.
To address the issue of potential rapid degradation of the JV N-
term protein CRFK cells were transfected with JV V5 RNA and
were harvested at designated time points following the addition of
the protein synthesis inhibitor cycloheximide. Cell lysates were
analysed by Western blot using the anti-V5 antibody (Figure 8).
The consistent appearance of the N-term/V5 protein suggested
that it is stable and insensitive to degradation by viral and host cell
proteases.
The predicted molecular weight of the JV N-term is 35.3 kDa,
based on the site of initiation of translation and location of
conserved cleavage sites. The appearance, therefore, of a
Figure 5. Analysis of TNTH (lane 2) and RIPA (lane 3) products
for JV/V5. The N-term/V5 product is approximately 42 kDa in size,
larger than the predicted size of 35.3 kDa. Molecular weight marker is
represented in lane 1.
doi:10.1371/journal.pone.0002169.g005
Figure 6. Confocal immunofluorescence of CRFK cells transfected with JV/V5 RNA. A= cells stained with wheat germ agglutinin (plasma
and Golgi/ER membrane marker, red) and DAPI (blue). B = cells stained with anti-V5 (green). C =merged.
doi:10.1371/journal.pone.0002169.g006
Figure 7. Western analysis from lysates of CRFK cells trans-
fected with no RNA (lane 2), JV RNA (lane 3) and JV/V5 RNA
(lane 4) using the anti-V5 monoclonal antibody. Bradford analysis
was performed on the lysates to ensure equal loading. The appearance
of the 42 kDa V5 product confirms ORF1 translation and activity of the
3C protease in vivo. Molecular weight marker is represented in lane 1.
doi:10.1371/journal.pone.0002169.g007
Analysis of the 59 GS of JV
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previously unseen 42 kDa protein in the in vitro transcription and
translation profile was unexpected but this protein does represent a
translation product for the JV 59GS. To date, it has not been
possible to explain the difference in the predicted and observed
sizes for the JV N-term, and the addition of the 14 amino acid V5
epitope within JV N-term does not account for this apparent large
shift in molecular weight. However, a recent study described a
similar anomaly when investigating proteolytic processing in the
murine norovirus MNV-1 [12]. The predicted molecular weight
for the MNV-1 N-term protein was 38.3 kDa. The authors
successfully generated antisera against the MNV-1 N-term and
used it to immunoprecipitate the protein from in vitro transcription
and translation reactions and observed that the N-term existed as a
45 kDa doublet, in addition to the predicted size of 38 kDa.
However, when MNV-1 N-term antisera was used to probe
MNV-1-infected cell lysates only the 43–45 kDa doublet and a
large 115 kDa precursor could be detected, suggesting that the
predicted 38 kDa form of the N-term is not generated in cell
culture. Again, it was not possible to conclusively determine the
cause of this discrepancy, but it was speculated that the N-term
protein may migrate abnormally in SDS-PAGE, or may be
proteolytically processed at a previously unknown cleavage site
downstream of the protein’s predicted C-terminus. It is also
possible that the N-term protein might be modified in some way
leading to a shift in observed molecular weight. At this time the
same conclusions would seem appropriate for the JV N-term. In
addition, it is not known why the JV N-term was previously not
detected in in vitro transcription and translation studies prior to the
insertion of the V5 epitope. It cannot be ruled out, however, that
the wild type JV N-term aberrantly co-migrates with the 39 kDa
JV 2C protein in SDS-PAGE. Indeed, the appearance of the V5/
N-term product from transfected cell lysates would appear to be
one of a doublet (Figure 8), also analogous to the observed
appearance of the MNV N-term protein in infected cells,
suggesting the likelihood of a further cleavage site within the JV
N-term protein which has yet to be elucidated. Nevertheless, these
studies clearly demonstrate that a protein representative of the
59GS of JV is translated both in vitro and in vivo and is
proteolytically processed from the ORF1 polyprotein following
translation initiation at nucleotide 22.
Conclusions
Human norovirus infection has been shown to be the leading
cause of non-bacterial gastroenteritis [31], however there is
currently no cell culture system available to facilitate viral
replication and ethical considerations have hindered progress in
establishing a permissive human organ culture system. The study
of Jena virus offers a potential animal model of enteric noroviral
infection. However, until a permissive bovine cell and/or organ
culture systems is established analysis of the molecular mechanisms
underpinning viral replication and pathogenesis rely upon in vitro
systems, most notably polyprotein synthesis and processing.
Unlike similarly studied human noroviruses JV initially did not
appear to express the N-terminal protein, presenting the possibility
that the encoding RNA sequence had a regulatory function itself,
most likely involved in translation initiation in an IRES-like
manner. This was shown not to be the case and, following
determination of the site of translation initiation at the predicted
nucleotide 22 the N-term protein was detected following the
insertion of an epitope tag, both in vitro and in vivo. Although
slightly larger than predicted the N-term protein was detected in a
processed form in vivo, thus not only demonstrating initial
translation of the ORF1 polyprotein but also activity of the viral
encoded protease. These important findings indicate that the block
to replication of enteric norovirus in cultured cells cannot be
attributed to a failure to synthesise and process the non-structural
proteins. The detection of processed and active ORF1 proteins in
transfected cultured cells, however, highlights the potential for the
development of cell and bovine organ based systems to facilitate
the replication of Jena virus.
Materials and Methods
Construction of Bi-cistronic vectors
The pEGFP-C1 vector (Clontech) comprises of an EGFP
coding sequence under the control of a CMV promoter and a
Kozak translation initiation site. Downstream of the EGFP
sequence is the multiple cloning site containing unique BglII, SacI,
HindIII and ApaI restriction sites. Contruction of pEGFP-C1/JV
59 GS/lacZ was as follows; The JV 59 GS sequence was amplified
from the JV full length cDNA clone [7] using Bio-X-Act DNA
polymerase (Bioline) with the primers 59 GS F (59-AACTGCA-
GATCTTAATAAGTGAATGAAGACTTTGACGAT-39), con-
taining the BglII restriction site (bold) and two in-frame translation
termination codons (underlined) to ensure that translation of the
EGFP sequence did not carry over to the 59 GS, and 59 GS R (59-
AACTGCAAGCTTCTGCAGGACACAATGAGG-39), contain-
ing theHindIII restriction site. The JV 59 GS amplicon was ligated
to the pEGFP-C1 vector, following restriction enzyme digestion of
both amplicon and vector with BglII and HindIII restriction
enzymes, and the ligated DNA used to transform E.coli Top10
(Invitrogen). This intermediate construct was named pEGFP-C1/
JV 59 GS. The lacZ coding sequence was amplified from the pSV-
b-Gal reporter vector (Promega) using Bio-X-Act DNA polymer-
ase and the primers lacZ F (59-AACTGCAAGCTTGA-
TATGGGGGATCCCGTCGTTTTACAACG-39), containing
the HindIII restriction site (bold) and a kozak translation initiation
site (underlined), and lacZ R (59-AACTGCGGGCCCTTAT-
TATTTTTGACACCAGACCA-39) containing the ApaI restric-
tion site (bold) and translation termination codons (underlined).
The lacZ amplicon was ligated to the pEGFP-C1/JV 59 GS vector
following restriction enzyme digest of both amplicon and vector
with HindIII and ApaI restriction enzymes, and the ligated DNA
used to transform E.coli Top10. The construct was verified by
sequencing. Construction of pEGFP-C1/IRES/lacZ was as
follows; The EMCV IRES sequence was amplified from the
pIRES2-EGFP vector (Clontech) using Bio-X-Act DNA polymer-
ase and the primers IRES Bgl F (59-ACTCGAAGATCTTAA-
TAGAGCTTCGAATTCTGCAGTCGA-39), containing the
BglII restriction site (bold) and translation termination codons
(underlined) to prevent carry over translation as before, and IRES
Sac R (59- ACTCGAGAGCTCTGTGGCCATATTATCATC-
GTG-39), containing the SacI restriction site (bold). The IRES
amplicon was ligated to the pEGFP-C1 vector follwing restriction
Figure 8. Degradation analysis of N-term/V5 following treat-
ment of JV/V5 transfected CRFK with cycloheximide (CHX).
Whole cell lysate was collected at the following time points following
CHX treatment: 0 hr, 1 hr, 3 hr, 6 hr, 12 hr, 24 hr. Bradford analysis was
performed on the lysates to ensure equal loading. Following Western
analysis the ECL treated membrane was exposed to film for 1 min.
Molecular weight marker is represented in lane 1.
doi:10.1371/journal.pone.0002169.g008
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enzyme digest of both amplicon and vector with BgIII and SacI
restriction enzymes, and the ligated DNA used to transform E.coli
Top10. The lacZ amplicon described previously was ligated to the
intermediate pEGFP-C1/IRES vector following restriction en-
zyme digest of both amplicon and vector with HindIII and ApaI
restriction enzymes, and the ligated DNA used to transform E.coli
Top10.
Construction of JV 3Cmut and JV 3Cmut/polySTOP
The JV 3C protease mutant was created by point mutation of
the critical TGT encoded cysteine residue, within the GDCG
active site motif, to a GGT encoded glycine residue by mutagenic
overlap PCR using Bio-X-Act DNA polymerase. Three rounds of
amplification using the JV full length cDNA clone as template
were used to generate the final mutant protease cassette. Round 1
used the primers JV F1 (59-CGTCTCAGGGTTGATACT-39)
and JV Mut 1 (59-GCAACCACCGTCACCAG-39), yielding a
222 bp amplicon (point mutation nucleotide shown in bold).
Round 2 used the primers JV Mut 2 (59-CTGGTGACGGT-
GGTTGC-39) and JV R2 (59-TTCCTGGGAGGAACAAGTT-
39), yielding a 651 bp amplicon. Amplicons generated in rounds 1
and 2 were pooled to serve as template for round 3 using the
primers JV NF (59-ATGTCAACCACCACCAGC –39) and JV
NR (59-AAGGGCTCCGGTGAAGG-39). This cassette contained
two BclI restriction sites flanking the 3Cprotease active site, as also
found in the wild-type full length clone. Restriction digest using
BclI was used to remove the appropriate wild-type cassette from
the JV full length clone. The mutant cassette was also digested
with BclI prior to ligation to the BclI-digested JV full length clone.
The ligated DNA was used to transform E.coli Top10, and was
designated JV 3Cmut.
Construction of JV 3Cmut/polySTOP was as follows: comple-
mentary oligonucleotides with three translation termination
codons (underlined) in each reading frame in sense and anti-sense
orientations were desgined in such a way that upon annealing the
duplex would contain blunt termini. The oligonucleotides were
termed pSTOP Top (59-CTAGGTAAGTAAACGCGTCTACT-
CACTCAC-39) and pSTOP Comp (59- GTGAGTGAGTA-
GACGCGTTTACTTCAATAG-39). Each oligo (1 mg) was
incubated with T4 polynucleotide kinase and ATP to phosphor-
ylate the 59 termini, pooled and heated to 75uC for 15 min, and
left to cool to room temperature to anneal the oligos. Following
purification the polySTOP duplex was ligated to Eco47III digested
JV 3Cmut, and ligated DNA was used to transform E.coli Top10.
The duplex contained the unique restriction site MluI (shown in
bold) to assist screening of recombinant clones.
Construction of JV V5
The V5 epitope (N-Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-Leu-Gly-
Leu-Asp-Ser-Thr-C) is recognized by the anti-V5 monoclonal
antibody (Invitrogen). Complementary oligonucleotides encoding
the V5 epitope were designed in such a way as to generate SacII
compatible termini following annealing (bold), and to preserve the
reading frame when inserted into the SacII restriction site at
nucleotide 123 within the 59 GS of the JV genome (underlined).
The oligos were termed V5 Top (59-GGTAAGCCTATCCC-
TAACCCTCTCCTCGGTCTCGATTCTACGAGC-39) and
V5 Comp (59-TCGTAGAATCGAGACCGAGGAGAGGGT-
TAGGGATAGGCTTACCGC-39). The oligos were phosphory-
lated and annealed as described previously and the duplex ligated
to the SacII digested JV full length clone. Ligated DNA was used to
transform E.coli Top10.
In vitro Transcription/Translation and RIPA analysis
In vitro coupled transcription and translation was performed
using the TNTH Coupled Reticulocyte Lysate System (Promega)
as per the manufacturer’s instructions. Reactions were incubated
at 30uC for 1–2 hr. For non-radiolabelled reactions the 35 S-
Methionine was replaced with 1 mM unlabelled Methionine
(2 ml). Reaction products (1–2 ml) were analysed by SDS-PAGE.
Gels were stained and prepared for autoradiography by incubating
for 30 min in a solution containing 32 g sodium salicylate, 100 ml
methanol and 100 ml dH2O. Gels were dried under vacuum and
the reaction products were detected by exposure to Kodak X-
Omat scientific imaging film (Sigma) at 270uC for 16 hr followed
by developing using a Kodak automated developer.
Specific V5-tagged proteins synthesised by TNTH were
precipitated from 5–10 ml of reaction product using the anti-V5
monoclonal antibody (Invitrogen) at the recommended dilution in
600 ml of 16RIPA buffer (diluted from 10x stock: 10 mM Tris-
HCl (pH 7.5), 1 mM EDTA, 0.15 mM NaCl, 0.1% SDS, 0.5%
Empigen BB, 0.1 mM phenylmethylsulphonylfluoride) for 1 hr at
37uC. This was followed by a second incubation of tube for 2 hr
rotating at room temperature with goat anti-mouse immuno-
globulin G agarose beads (Sigma) to absorb the immune
complexes. The beads were washed three times with 500 ml 16
RIPA buffer and once with 500 ml PBS. The beads were
resuspended in sample buffer for analysis by SDS-PAGE and
autoradiography as before.
Transfection of CRFK cells with Bi-cistronic vectors
Endotoxin-free preparations of plasmid DNA were prepared
using the GenEluteTM Endotoxin free plasmid midi prep kit
(Sigma). Crandall-Reese Feline Kidney cells (CRFKs) were
seeded into a 12 well tray at approximately 40–50% confluence.
CRFK cells were transfected with no DNA (negative control),
pSV-b-Gal (control for b-galactosidase activity), pEGFP-C1/JV
59 GS/lacZ and pEGFP-C1/IRES/lacZ (control for IRES
activity) using the SuperfectTM transfection reagent (Qiagen) as
per the manufacturer’s recommendations. Following a 16 hour
incubation the cells were observed for EGFP expression using a
Leica Leitz DMRB fluorescence microscope. The cells were
washed in PBS and fixed using a 0.5% solution of glutaraldehyde
for 30 min at room temperature. The cells were incubated with
an X-Gal stain solution: 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6,
2 mM MgCl2, 1x X-Gal (Sigma) for 4 hours at 37uC and were
observed for b-glactosidase activity by light microscopy. The
experiment was performed more than once to confirm the
results.
RNA synthesis and transfection of CRFK cells
JV V5 and JV FLC T7 cDNA plasmid constructs were
linearised using NdeI (Invitrogen). Capped RNA was synthesised
using the mMessage mMachineH Capped RNA Transcription kit
(Ambion) according to the manufacturer’s instructions. CRFK
cells were seeded into 6 well trays at approximately 50%
confluence and were transfected with 2 mg purified RNA per well
using Transmessenger transfection reagent (Qiagen) according to
the manufacturer’s instructions.
Immunological analysis
For immunofluorescence CRFK cells were seeded onto 19 mm
coverslips in 6 well trays and were transfected with RNA as
described. Following a 24 hr incubation the coverslips were
washed with PBS and fixed in 4% formaldehyde for 15 min at
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room temperature. Cells were permeabilised and blocked in
saponin buffer, also used as staining buffer, (0.1% saponin, 10%
foetal calf serum, 0.1% sodium azide) for 1 hr at 4uC. Cells were
stained using an anti-V5 monoclonal antibody (Invitrogen)
followed by an anti-mouse Alexafluor 488 conjugated secondary
antibody (Molecular Probes) at the recommended dilution in
staining buffer for 30 min in the dark. Cells were then stained for
30 min in the dark with a Wheat Germ Agglutinin Alexafluor
594 nm conjugate (Molcular Probes) to allow identification of
plasma and Golgi membranes. Coverslips were washed and
mounted onto slides using Vectashield containing DAPI (Vector
Labs). Microscopy was performed using an inverted Leica TCS-
NT confocal laser scanning microscope.
The anti-V5 antibody was also used to detect V5-tagged protein
by Western blot. Cell lysates were prepared following transfection
using lysis buffer (0.15 M sodium chloride, 0.5% (v/v) sodium
deoxycholate, 0.1% (w/v) SDS, 50 mM Tris-Cl pH 8.0) and
protease inhibitor cocktail (Sigma). Lysates were incubated for
15 min on ice followed by sonication to shear genomic DNA.
Following Bradford analysis equal protein content from JV V5 and
JV FLC lysates were run on a 10% SDS-PAGE gel and
subsequently transferred onto Immobilon-P PVDF membrane
(Millipore) according to the manufacturer’s recommendations.
The membrane was probed using the anti-V5 monoclonal
antibody at the manufacturer’s recommended dilution, followed
by an anti-mouse HRP-copnjugated secondary antibody (Santa
Cruz) at the recommended diltution. The ECL Western blotting
reagents kit (G.E. Healthcare) was used to detect antibody bound
protein, which was visualised by exposure to BioMax Light film
(Kodak).
Degradation analysis
CRFK cells were seeded into 6 well trays and transfected with
capped JV V5 RNA as described. Following a 24 hr incubation
cycloheximide (Sigma) was added to the cells at a final
concentration of 50 mg/ml. Cells were harvested at indicated
times for the preparation of lysates for V5 Western analysis as
described above. Bradford reagent (Sigma) was used to ensure
equal loading of lysates according to the manufacturer’s
recommendations.
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